Faculty of 1000 evaluation for A Randomized, Double-Blind, Placebo Controlled Trial of Adalimumab in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 191
(1)
◽
pp. 77-82
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 193
(3)
◽
pp. 857-862
◽
Keyword(s):